The subchronic phencyclidine rat model: relevance for the assessment of novel therapeutics for cognitive impairment associated with schizophrenia (Q38526546)

From Wikidata

Jump to navigation Jump to search

scientific article published on 14 June 2015

Language	Label	Description	Also known as
English	The subchronic phencyclidine rat model: relevance for the assessment of novel therapeutics for cognitive impairment associated with schizophrenia	scientific article published on 14 June 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1 reference

Europe PubMed Central

The subchronic phencyclidine rat model: relevance for the assessment of novel therapeutics for cognitive impairment associated with schizophrenia (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1 reference

based on heuristic

inferred from title

cognitive dysfunction

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26070547%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Sanna K Janhunen

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26070547%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Heta Svärd

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26070547%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Gaurav Kumar

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26070547%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Thomas Steckler

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26070547%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Niels Plath

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26070547%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Linda Lerdrup

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26070547%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Trine Ruby

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26070547%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Marie Haman

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26070547%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Roger Wyler

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26070547%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Theresa M Ballard

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26070547%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

14 June 2015

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

number of pages

25

1 reference

based on heuristic

inferred from page(s)

Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26070547%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

232

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26070547%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

21-22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26070547%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

4059-4083

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26070547%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Effects of single and repeated phencyclidine administration on [3H]flunitrazepam binding in rat brain

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Effects of single and repeated phencyclidine administration on the expression of metabotropic glutamate receptor subtype mRNAs in rat brain

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Effect of clozapine, haloperidol, or M100907 on phencyclidine-activated glutamate efflux in the prefrontal cortex

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Extensive cytotoxic lesions involving both the rhinal cortices and area TE impair recognition but spare spatial alternation in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Spatial memory deficits induced by perinatal treatment of rats with PCP and reversal effect of D-serine

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Cognition in schizophrenia: core psychological and neural mechanisms

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Aged rats are impaired on an attentional set-shifting task sensitive to medial frontal cortex damage in young rats.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Perceptual functions of perirhinal cortex in rats: zero-delay object recognition and simultaneous oddity discriminations.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Subchronic phencyclidine in rats: alterations in locomotor activity, maze performance, and GABA(A) receptor binding

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory'.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Effects of orbitofrontal, infralimbic and prelimbic cortical lesions on serial spatial reversal learning in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Integrative role for serotonergic and glutamatergic receptor mechanisms in the action of NMDA antagonists: potential relationships to antipsychotic drug actions on NMDA antagonist responsiveness

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Reversal of cognitive deficits by an ampakine (CX516) and sertindole in two animal models of schizophrenia--sub-chronic and early postnatal PCP treatment in attentional set-shifting.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Altered NMDA Sensitivity and Learning Following Chronic Developmental NMDA Antagonism

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Schizophrenia-like GABAergic gene expression deficits in cerebellar Golgi cells from rats chronically exposed to low-dose phencyclidine

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

The perceptual-mnemonic/feature conjunction model of perirhinal cortex function.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Role of the aromatic group in the inhibition of phencyclidine binding and dopamine uptake by PCP analogs

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Recovery of neuropsychological functions during reduction in use of phencyclidine

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Applications of the Morris water maze in the study of learning and memory

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors reverses sub-chronic PCP-induced deficits in the novel object recognition task in rats.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Extrasynaptic GABAA receptor activation reverses recognition memory deficits in an animal model of schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Modafinil Reverses Phencyclidine-Induced Deficits in Cognitive Flexibility, Cerebral Metabolism, and Functional Brain Connectivity

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Sustained NMDA receptor hypofunction induces compromised neural systems integration and schizophrenia-like alterations in functional brain networks.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Effects of risperidone, clozapine and the 5-HT6 antagonist GSK-742457 on PCP-induced deficits in reversal learning in the two-lever operant task in male Sprague Dawley rats

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Rule shift under long-term PCP challenge in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Reversal of PCP-induced learning and memory deficits in the Morris' water maze by sertindole and other antipsychotics

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Asenapine effects on cognitive and monoamine dysfunction elicited by subchronic phencyclidine administration

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Loss of asymmetric spine synapses in dorsolateral prefrontal cortex of cognitively impaired phencyclidine-treated monkeys

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Phencyclidine-induced Loss of Asymmetric Spine Synapses in Rodent Prefrontal Cortex is Reversed by Acute and Chronic Treatment with Olanzapine

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Neurotoxic lesions of the perirhinal cortex do not mimic the behavioural effects of fornix transection in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Re-evaluating the PCP challenge as a pre-clinical model of impaired cognitive flexibility in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Dissociable roles of medial orbitofrontal cortex in human operant extinction learning

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Sensitization to amphetamine, but not PCP, impairs attentional set shifting: reversal by a D1 receptor agonist injected into the medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Hippocampal lesions that abolish spatial maze performance spare object recognition memory at delays of up to 48 hours.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Course of recovery of cognitive impairment in patients with schizophrenia: a randomised double-blind study comparing sertindole and haloperidol.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Comparison of haloperidol, risperidone, sertindole, and modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat--a back translational study

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Erythropoietin reverses the attentional set-shifting impairment in a rodent schizophrenia disease-like model

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Performance of schizophrenic patients on putative neuropsychological tests of frontal lobe function.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Working memory dysfunction in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Dopamine system dysregulation by the hippocampus: implications for the pathophysiology and treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

The involvement of distraction in memory deficits induced by NMDAR antagonism: relevance to cognitive deficits in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Subchronic phencyclidine treatment decreases the number of dendritic spine synapses in the rat prefrontal cortex

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Impairment on the hippocampal-dependent virtual Morris water task in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and D-serine.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective alpha7 nicotinic receptor agonist SSR180711.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

D(1) receptor agonists reverse the subchronic phencyclidine (PCP)-induced novel object recognition (NOR) deficit in female rats

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Prevention of the phencyclidine-induced impairment in novel object recognition in female rats by co-administration of lurasidone or tandospirone, a 5-HT(1A) partial agonist

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Interaction of mGlu2/3 agonism with clozapine and lurasidone to restore novel object recognition in subchronic phencyclidine-treated rats

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

The Role of 5-Hydroxytryptamine 7 Receptors in the Phencyclidine-Induced Novel Object Recognition Deficit in Rats

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

The role of 5-HT1A receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Blonanserin reverses the phencyclidine (PCP)-induced impairment in novel object recognition (NOR) in rats: role of indirect 5-HT(1A) partial agonism

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

A microsatellite repeat in the promoter of the N-methyl-D-aspartate receptor 2A subunit (GRIN2A) gene suppresses transcriptional activity and correlates with chronic outcome in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Disturbances in social interaction occur along with pathophysiological deficits following sub-chronic phencyclidine administration in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Effect of subchronic phencyclidine administration on sucrose preference and hippocampal parvalbumin immunoreactivity in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Impaired inhibition of conditioned responses produced by subchronic administration of phencyclidine to rats

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Altered frontal cortical dopaminergic transmission in monkeys after subchronic phencyclidine exposure: involvement in frontostriatal cognitive deficits

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Subchronic Phencyclidine Administration Reduces Mesoprefrontal Dopamine Utilization and Impairs Prefrontal Cortical-Dependent Cognition in the Rat

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Behavioural rigidity and rule-learning deficits following isolation-rearing in the rat: neurochemical correlates

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent subchronic administration of donepezil: role of sigma-1 receptors.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Effects of ketamine in normal and schizophrenic volunteers

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Habenula lesions cause impaired cognitive performance in rats: implications for schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: stability over six years and specific associations with medication type and disorganization syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Effect of repeated administration of phencyclidine on spatial performance in an eight-arm radial maze with delay in rats and mice

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Brexpiprazole II: antipsychotic-like and procognitive effects of a novel serotonin-dopamine activity modulator

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Delayed alternation performance following subchronic phencyclidine administration in rats depends on task parameters.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Schizophrenia-like syndrome inducing agent phencyclidine failed to impair memory for temporal order in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Effect of pretreatment with risperidone on phencyclidine-induced disruptions in object recognition memory and prefrontal cortex parvalbumin immunoreactivity in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

A preliminary investigation into the effects of antipsychotics on sub-chronic phencyclidine-induced deficits in attentional set-shifting in female rats

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: implications for therapy of cognitive dysfunction in schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

PNU-120596, a positive allosteric modulator of α7 nicotinic acetylcholine receptors, reverses a sub-chronic phencyclidine-induced cognitive deficit in the attentional set-shifting task in female rats.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

D(1)-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Effects of asenapine, olanzapine, and risperidone on psychotomimetic-induced reversal-learning deficits in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Role of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Translating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Capturing the angel in "angel dust": twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Developments of a water-maze procedure for studying spatial learning in the rat

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Visual perception and memory: a new view of medial temporal lobe function in primates and rodents

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Dopamine D1 receptors regulate protein synthesis-dependent long-term recognition memory via extracellular signal-regulated kinase 1/2 in the prefrontal cortex

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Opposing short- and long-term effects on muscarinic M1/4 receptor binding following chronic phencyclidine treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Short and long term changes in NMDA receptor binding in mouse brain following chronic phencyclidine treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Identification of separable cognitive factors in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Orbitofrontal cortex mediates outcome encoding in Pavlovian but not instrumental conditioning.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Relationship of behavioural and symptomatic syndromes in schizophrenia to spatial working memory and attentional set-shifting ability.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Chronic phencyclidine increases synapsin-1 and synaptic adaptation proteins in the medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Visual presentation of novel objects and new spatial arrangements of objects differentially activates the medial temporal lobe subareas in humans.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Performance of male C57BL/6J mice and Wistar rats in the water maze following various schedules of phencyclidine treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Translational Aspects of the Novel Object Recognition Task in Rats Abstinent Following Sub-Chronic Treatment with Phencyclidine (PCP): Effects of Modafinil and Relevance to Cognitive Deficits in Schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Negative modulation of GABAA α5 receptors by RO4938581 attenuates discrete sub-chronic and early postnatal phencyclidine (PCP)-induced cognitive deficits in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartate and N-acetylaspartylglutamate in rat brain

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Identification of single nucleotide polymorphisms (SNPs) and other sequence changes and estimation of nucleotide diversity in coding and flanking regions of the NMDAR1 receptor gene in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

The case of frontostriatal dysfunction in schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Reversal of subchronic PCP-induced deficits in attentional set shifting in rats by sertindole and a 5-HT6 receptor antagonist: comparison among antipsychotics.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Role of the σ receptor in the inhibition of [3H]-noradrenaline uptake in brain synaptosomes and adrenal chromaffin cells

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Estradiol attenuates the cognitive deficits in the novel object recognition task induced by sub-chronic phencyclidine in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Animal cognition: defining the issues

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Cerebral changes and cognitive dysfunctions in medication-free schizophrenia - an fMRI study

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Neuropsychological functioning in bipolar disorder and schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Neuroleptics ameliorate phencyclidine-induced impairments of short-term memory

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Effects of modafinil on cognitive functions in first episode psychosis

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Effect of an NCAM mimetic peptide FGL on impairment in spatial learning and memory after neonatal phencyclidine treatment in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Subsequent exposure to the choline uptake enhancer MKC-231 antagonizes phencyclidine-induced behavioral deficits and reduction in septal cholinergic neurons in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Repeated neonatal phencyclidine treatment impairs performance of a spatial task in juvenile rats.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Attenuation of phencyclidine-induced object recognition deficits by the combination of atypical antipsychotic drugs and pimavanserin (ACP 103), a 5-hydroxytryptamine(2A) receptor inverse agonist.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Asenapine improves phencyclidine-induced object recognition deficits in the rat: evidence for engagement of a dopamine D1 receptor mechanism

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Effects of repeated treatment with amphetamine or phencyclidine on working memory in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

The atypical antipsychotic drug clozapine enhances chronic PCP-induced regulation of prefrontal cortex 5-HT2A receptors

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Chronic phencyclidine (PCP)-induced modulation of muscarinic receptor mRNAs in rat brain : Impact of antipsychotic drug treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Effects of discrete kainic acid-induced hippocampal lesions on spatial and contextual learning and memory in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Attentional set-shifting in rodents: a review of behavioural methods and pharmacological results.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Effects of quetiapine on phencyclidine-induced cognitive deficits in mice: a possible role of alpha1-adrenoceptors

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Decrements in volume of anterior ventromedial temporal lobe and olfactory dysfunction in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

The effects of phencyclidine pretreatment on amphetamine-induced behavior and c-Fos expression in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Prefrontal brain network connectivity indicates degree of both schizophrenia risk and cognitive dysfunction

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Alterations in local cerebral glucose utilization induced by phencyclidine

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

A combined metabonomic and proteomic approach identifies frontal cortex changes in a chronic phencyclidine rat model in relation to human schizophrenia brain pathology

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Double dissociation between the effects of peri-postrhinal cortex and hippocampal lesions on tests of object recognition and spatial memory: heterogeneity of function within the temporal lobe.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

A review of modafinil and armodafinil as add-on therapy in antipsychotic-treated patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Cognitive impairment of executive function as a core symptom of schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Compromised memory function in schizophrenia and temporal lobe epilepsy

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

Neuropsychological evidence for frontostriatal dysfunction in schizophrenia

2 references

https://api.crossref.org/works/10.1007%2FS00213-015-3954-6

21 January 2018

https://pubmed.ncbi.nlm.nih.gov/26070547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primate analogue of the Wisconsin Card Sorting Test: effects of excitotoxic lesions of the prefrontal cortex in the marmoset

1 reference

https://pubmed.ncbi.nlm.nih.gov/26070547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential expression of GABA(A) receptor subunit mRNAs and ligand binding sites in rat brain following phencyclidine administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/26070547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phencyclidine increases forebrain monoamine metabolism in rats and monkeys: modulation by the isomers of HA966.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26070547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of cognitive functioning in the outcome of those at clinical high risk for developing psychosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26070547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/26070547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of repeated phencyclidine treatment on serotonin transporter in rat brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/26070547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytotoxic lesion of the medial prefrontal cortex abolishes the partial reinforcement extinction effect, attenuates prepulse inhibition of the acoustic startle reflex and induces transient hyperlocomotion, while sparing spontaneous object recognition

1 reference

https://pubmed.ncbi.nlm.nih.gov/26070547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modelling prefrontal cortex deficits in schizophrenia: implications for treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/26070547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired recognition memory in rats after damage to the hippocampus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26070547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Executive dysfunction in first-episode schizophrenia and relationship to duration of untreated psychosis: the West London Study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26070547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phencyclidine-induced alteration in rat muscarinic cholinergic receptor regulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26070547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[11C]CHIBA-1001 as a novel PET ligand for alpha7 nicotinic receptors in the brain: a PET study in conscious monkeys.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26070547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Object versus spatial visual mental imagery in patients with schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26070547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics

1 reference

https://pubmed.ncbi.nlm.nih.gov/26070547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Delayed regional metabolic actions of phencyclidine

1 reference

https://pubmed.ncbi.nlm.nih.gov/26070547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of lamotrigine on PCP-evoked elevations in monoamine levels in the medial prefrontal cortex of freely moving rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/26070547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of tolerance and supersensitivity to phencyclidine in rats after repeated administration of phencyclidine

1 reference

https://pubmed.ncbi.nlm.nih.gov/26070547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subchronic phencyclidine exposure potentiates the behavioral and c-Fos response to stressful stimuli in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/26070547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medial frontal cortex mediates perceptual attentional set shifting in the rat.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26070547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spatial learning impairment parallels the magnitude of dorsal hippocampal lesions, but is hardly present following ventral lesions.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26070547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dissociable contributions of the orbitofrontal and infralimbic cortex to pavlovian autoshaping and discrimination reversal learning: further evidence for the functional heterogeneity of the rodent frontal cortex.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26070547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired limbic cortico-striatal structure and sustained visual attention in a rodent model of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26070547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical data reproducibility for R&D--the challenge for neuroscience

1 reference

https://pubmed.ncbi.nlm.nih.gov/26070547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00213-015-3954-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26070547%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26070547%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38526546&oldid=2201796573"